U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Central Chondrosarcoma, Grade 3

MedGen UID:
1791522
•Concept ID:
C5555081
•
Neoplastic Process

Definition

A high-grade chondrosarcoma arising in the medulla of bone. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVCentral Chondrosarcoma, Grade 3

Professional guidelines

PubMed

Effect of Cryoablation Treatment on the Protein Expression Profile of Low-Grade Central Chondrosarcoma Identified by LC-ESI-MS/MS.
Madda R, Chen CM, Chen CF, Wang JY, Wu PK, Chen WM
J Am Soc Mass Spectrom 2021 Jun 2;32(6):1469-1489. Epub 2021 May 18 doi: 10.1021/jasms.1c00068. PMID: 34003650
Conventional Primary Central Chondrosarcoma of the Pelvis: Prognostic Factors and Outcome of Surgical Treatment in 162 Patients.
Bus MPA, Campanacci DA, Albergo JI, Leithner A, van de Sande MAJ, Gaston CL, Caff G, Mettelsiefen J, Capanna R, Tunn PU, Jeys LM, Dijkstra PDS
J Bone Joint Surg Am 2018 Feb 21;100(4):316-325. doi: 10.2106/JBJS.17.00105. PMID: 29462035
Treatment strategies for central low-grade chondrosarcoma of long bones: a systematic review of the literature and meta-analysis.
Shemesh SS, Acevedo-Nieves JD, Pretell-Mazzini J
Musculoskelet Surg 2018 Aug;102(2):95-109. Epub 2017 Oct 6 doi: 10.1007/s12306-017-0507-7. PMID: 28986742

Recent clinical studies

Etiology

Bone and soft tissue tumors at the borderlands of malignancy.
Crim J, Layfield LJ
Skeletal Radiol 2023 Mar;52(3):379-392. Epub 2022 Jun 29 doi: 10.1007/s00256-022-04099-1. PMID: 35767018
Intralesional treatment versus wide resection for central low-grade chondrosarcoma of the long bones.
Dierselhuis EF, Goulding KA, Stevens M, Jutte PC
Cochrane Database Syst Rev 2019 Mar 7;3(3):CD010778. doi: 10.1002/14651858.CD010778.pub2. PMID: 30845364Free PMC Article
Is intralesional resection suitable for central grade 1 chondrosarcoma: A systematic review and updated meta-analysis.
Chen X, Yu LJ, Peng HM, Jiang C, Ye CH, Zhu SB, Qian WW
Eur J Surg Oncol 2017 Sep;43(9):1718-1726. Epub 2017 Jun 14 doi: 10.1016/j.ejso.2017.05.022. PMID: 28666625
Intralesional curettage of central low-grade chondrosarcoma: A midterm follow-up study.
Chen YC, Wu PK, Chen CF, Chen WM
J Chin Med Assoc 2017 Mar;80(3):178-182. Epub 2016 Nov 23 doi: 10.1016/j.jcma.2016.10.002. PMID: 27889461
Dedifferentiated chondrosarcoma.
Mercuri M, Picci P, Campanacci L, Rulli E
Skeletal Radiol 1995 Aug;24(6):409-16. doi: 10.1007/BF00941235. PMID: 7481896

Diagnosis

Bone and soft tissue tumors at the borderlands of malignancy.
Crim J, Layfield LJ
Skeletal Radiol 2023 Mar;52(3):379-392. Epub 2022 Jun 29 doi: 10.1007/s00256-022-04099-1. PMID: 35767018
The role of surgical margins in chondrosarcoma.
Stevenson JD, Laitinen MK, Parry MC, Sumathi V, Grimer RJ, Jeys LM
Eur J Surg Oncol 2018 Sep;44(9):1412-1418. Epub 2018 Jun 8 doi: 10.1016/j.ejso.2018.05.033. PMID: 29929901
MRI differentiation of low-grade from high-grade appendicular chondrosarcoma.
Douis H, Singh L, Saifuddin A
Eur Radiol 2014 Jan;24(1):232-40. Epub 2013 Sep 10 doi: 10.1007/s00330-013-3003-y. PMID: 24337911
The clinical approach towards chondrosarcoma.
Gelderblom H, Hogendoorn PC, Dijkstra SD, van Rijswijk CS, Krol AD, Taminiau AH, Bovée JV
Oncologist 2008 Mar;13(3):320-9. doi: 10.1634/theoncologist.2007-0237. PMID: 18378543
Dedifferentiated chondrosarcoma.
Mercuri M, Picci P, Campanacci L, Rulli E
Skeletal Radiol 1995 Aug;24(6):409-16. doi: 10.1007/BF00941235. PMID: 7481896

Therapy

A Systematic Review of Adjuvant Chemotherapy in Localized Dedifferentiated Chondrosarcoma.
Tsukamoto S, Mavrogenis AF, Nitta Y, Righi A, Masunaga T, Honoki K, Fujii H, Kido A, Tanaka Y, Tanaka Y, Errani C
Curr Oncol 2024 Jan 19;31(1):566-578. doi: 10.3390/curroncol31010040. PMID: 38275833Free PMC Article
Intralesional treatment versus wide resection for central low-grade chondrosarcoma of the long bones.
Dierselhuis EF, Goulding KA, Stevens M, Jutte PC
Cochrane Database Syst Rev 2019 Mar 7;3(3):CD010778. doi: 10.1002/14651858.CD010778.pub2. PMID: 30845364Free PMC Article
Synergistic anti-proliferative effects of mTOR and MEK inhibitors in high-grade chondrosarcoma cell line OUMS-27.
Fukumoto S, Kanbara K, Neo M
Acta Histochem 2018 Feb;120(2):142-150. Epub 2018 Feb 3 doi: 10.1016/j.acthis.2018.01.002. PMID: 29397960
Treatment strategies for central low-grade chondrosarcoma of long bones: a systematic review of the literature and meta-analysis.
Shemesh SS, Acevedo-Nieves JD, Pretell-Mazzini J
Musculoskelet Surg 2018 Aug;102(2):95-109. Epub 2017 Oct 6 doi: 10.1007/s12306-017-0507-7. PMID: 28986742
New chondrosarcoma cell lines and mouse models to study the link between chondrogenesis and chemoresistance.
Monderer D, Luseau A, Bellec A, David E, Ponsolle S, Saiagh S, Bercegeay S, Piloquet P, Denis MG, Lodé L, Rédini F, Biger M, Heymann D, Heymann MF, Le Bot R, Gouin F, Blanchard F
Lab Invest 2013 Oct;93(10):1100-14. Epub 2013 Aug 19 doi: 10.1038/labinvest.2013.101. PMID: 23958880

Prognosis

IDH mutations in G2-3 conventional central bone chondrosarcoma: a mono institutional experience.
Setola E, Benini S, Righi A, Gamberi G, Carretta E, Ferrari C, Avnet S, Palmerini E, Magagnoli G, Gambarotti M, Lollini PL, Cesari M, Cocchi S, Paioli A, Longhi A, Scotlandi K, Laginestra MA, Donati DM, Baldini N, Ibrahim T
BMC Cancer 2023 Sep 26;23(1):907. doi: 10.1186/s12885-023-11396-y. PMID: 37752419Free PMC Article
Clinical differences between central and peripheral chondrosarcomas.
Laitinen MK, Evans S, Stevenson J, Sumathi V, Kask G, Jeys LM, Parry MC
Bone Joint J 2021 May;103-B(5):984-990. doi: 10.1302/0301-620X.103B5.BJJ-2020-1082.R2. PMID: 33934657
Intralesional treatment versus wide resection for central low-grade chondrosarcoma of the long bones.
Dierselhuis EF, Goulding KA, Stevens M, Jutte PC
Cochrane Database Syst Rev 2019 Mar 7;3(3):CD010778. doi: 10.1002/14651858.CD010778.pub2. PMID: 30845364Free PMC Article
Intralesional curettage of central low-grade chondrosarcoma: A midterm follow-up study.
Chen YC, Wu PK, Chen CF, Chen WM
J Chin Med Assoc 2017 Mar;80(3):178-182. Epub 2016 Nov 23 doi: 10.1016/j.jcma.2016.10.002. PMID: 27889461
Dedifferentiated chondrosarcoma.
Mercuri M, Picci P, Campanacci L, Rulli E
Skeletal Radiol 1995 Aug;24(6):409-16. doi: 10.1007/BF00941235. PMID: 7481896

Clinical prediction guides

IDH mutations in G2-3 conventional central bone chondrosarcoma: a mono institutional experience.
Setola E, Benini S, Righi A, Gamberi G, Carretta E, Ferrari C, Avnet S, Palmerini E, Magagnoli G, Gambarotti M, Lollini PL, Cesari M, Cocchi S, Paioli A, Longhi A, Scotlandi K, Laginestra MA, Donati DM, Baldini N, Ibrahim T
BMC Cancer 2023 Sep 26;23(1):907. doi: 10.1186/s12885-023-11396-y. PMID: 37752419Free PMC Article
Intralesional treatment versus wide resection for central low-grade chondrosarcoma of the long bones.
Dierselhuis EF, Goulding KA, Stevens M, Jutte PC
Cochrane Database Syst Rev 2019 Mar 7;3(3):CD010778. doi: 10.1002/14651858.CD010778.pub2. PMID: 30845364Free PMC Article
Treatment strategies for central low-grade chondrosarcoma of long bones: a systematic review of the literature and meta-analysis.
Shemesh SS, Acevedo-Nieves JD, Pretell-Mazzini J
Musculoskelet Surg 2018 Aug;102(2):95-109. Epub 2017 Oct 6 doi: 10.1007/s12306-017-0507-7. PMID: 28986742
Is intralesional resection suitable for central grade 1 chondrosarcoma: A systematic review and updated meta-analysis.
Chen X, Yu LJ, Peng HM, Jiang C, Ye CH, Zhu SB, Qian WW
Eur J Surg Oncol 2017 Sep;43(9):1718-1726. Epub 2017 Jun 14 doi: 10.1016/j.ejso.2017.05.022. PMID: 28666625
Intralesional curettage of central low-grade chondrosarcoma: A midterm follow-up study.
Chen YC, Wu PK, Chen CF, Chen WM
J Chin Med Assoc 2017 Mar;80(3):178-182. Epub 2016 Nov 23 doi: 10.1016/j.jcma.2016.10.002. PMID: 27889461

Recent systematic reviews

Wide surgical margins may be necessary to reduce recurrence and mortality in patients with localized periosteal chondrosarcoma: retrospective analysis of twenty three patients and literature meta-analysis.
Masunaga T, Tsukamoto S, Honoki K, Fujii H, Tanaka Y, Ishida Y, Tanaka Y, Mavrogenis A, Errani C, Kawai A
Int Orthop 2025 Jan;49(1):279-288. Epub 2024 Nov 21 doi: 10.1007/s00264-024-06371-6. PMID: 39570338
A Systematic Review of Adjuvant Chemotherapy in Localized Dedifferentiated Chondrosarcoma.
Tsukamoto S, Mavrogenis AF, Nitta Y, Righi A, Masunaga T, Honoki K, Fujii H, Kido A, Tanaka Y, Tanaka Y, Errani C
Curr Oncol 2024 Jan 19;31(1):566-578. doi: 10.3390/curroncol31010040. PMID: 38275833Free PMC Article
Intralesional treatment versus wide resection for central low-grade chondrosarcoma of the long bones.
Dierselhuis EF, Goulding KA, Stevens M, Jutte PC
Cochrane Database Syst Rev 2019 Mar 7;3(3):CD010778. doi: 10.1002/14651858.CD010778.pub2. PMID: 30845364Free PMC Article
Treatment strategies for central low-grade chondrosarcoma of long bones: a systematic review of the literature and meta-analysis.
Shemesh SS, Acevedo-Nieves JD, Pretell-Mazzini J
Musculoskelet Surg 2018 Aug;102(2):95-109. Epub 2017 Oct 6 doi: 10.1007/s12306-017-0507-7. PMID: 28986742
Is intralesional resection suitable for central grade 1 chondrosarcoma: A systematic review and updated meta-analysis.
Chen X, Yu LJ, Peng HM, Jiang C, Ye CH, Zhu SB, Qian WW
Eur J Surg Oncol 2017 Sep;43(9):1718-1726. Epub 2017 Jun 14 doi: 10.1016/j.ejso.2017.05.022. PMID: 28666625

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...